Puration Inc (OTCMKTS: PURA) has been running up the chrarts in recent days after the Company scheduled an earnings update as well as new information on the company’s ongoing acquisition campaign to expand its CBD infused consumer product reach. PURA reported $1.6 million in sales year to date through Q2 2020. The company reported just shy of $1.1 million for the same period last year. PURA’s sales growth YTD compared to the same period last year is 48%.
the stock has been on the move in recent days popping over the $0.02 mark on a surge of volume. PURA has runner in its blood and skyrocketed to highs of $0.25 back in 2018; a run that microcapdaily reported on. PURA recently secured a $5 million investment to fund its acquisition campaign in January, the company has acquired a CBD confections business, a CBD pet products business and CBD sun care business.
Puration Inc (OTCMKTS: PURA) started off as a water purification company that began to explore and develop new business opportunities focusing on the emerging Cannabis Extractions Sector. The Company is now emerging as aa leading Texas-based, CBD-infused beverage provider. The Company is focused on growing the distribution and sales of its product line both domestically and internationally. Along these lines, the Company acquired a German entity in December of 2019 to expand European distribution. During the Quarter ending September 30, 2017, the Company announced the acquisition of a 25-greenhouse grow operation located in East Texas known as First Choice Nursery.
The Company launched its EVERx CBD Infused Sports Waters in the spring of 2017 at Arnold Schwarzenegger’s Arnold Sports Festival. EVERx has since become the leading CBD infused beverage in the sports nutrition market place. The company’s sales grew 600% in the first year after the launch of EVERx. Kiwi Strawberry and Lemon Lime flavors are now available in addition to the Original EVERx CBD Infused Sports Water.
EVERx has more than twice the CBD of most CBD infused waters on the market. A proprietary technology enables EVERx to suspend more CBD than its competitors and still have a crystal-clear appearance and a refreshing taste. The company has recently initiated a package redesign after extensive market testing of a new logo design. Consumer demand for CBD infused beverages is growing and Puration is likewise receiving inquiries from a broader array of retail outlets. The package redesign is the first step of a comprehensive marketing plan to dramatically increase EVERx sales over the next 24 months.
To Find out the inside Scoop on PURA Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
On August 25 PURA reported it has exceeded $3 million in revenue over the trailing 12 months. Last week, the company published its Q2 2020 financials reporting $1.6 million in sales year-to-date (YTD) representing 48% revenue growth compared to the same period last year. Today, management is publishing a comprehensive update that includes a review of the Q2 2020 report and the latest information on a pending 1 for 1 dividend anticipated to be issued soon to PURA shareholders in addition to new information on a surprise second 1 for 1 dividend opportunity. The report also includes the latest on the company’s ongoing acquisition campaign to expand horizontally from its existing CBD infused beverage market into an addition $500 billion market opportunity. The update is included in its entirety below:
PURA remains resilient through the COVID-19 Pandemic reporting 48% sales growth YTD compared to the same period last year. The company realized $1.6 million in revenue with $471,000 in gross profit primarily from sales of its EVERx CBD Sports Water. PURA expects to maintain resilient sales throughout the year. At the same time the company continues to position itself as an overall CBD infused consumer products company through its ongoing acquisition campaign.
In January of this year, PURA initiated an acquisition campaign to introduce a solution to the cannabis sector-wide challenge with access to capital by leveraging its own core competencies to acquire CBD infused beverage, edible and topical businesses. PURA targets CBD product acquisitions that can be enhanced with PURA’s patented technology. PURA owns a license to a U.S. Patented cannabis extraction process backed by extensive university medical research. The license, issued by NCM Biotech, is exclusive for beverages, edibles and cosmetics among other uses. NCM Biotech is focused on medical research and Puration has access to that research. See a recent research report on CBD extracts derived from NCM Biotech’s patented extraction process: Journal of Cannabis Research.
— PotVestor (@PotVestor) August 25, 2020
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $19 million market valuation PURA is an exciting story developing in small caps; the Comapany is experiencing growth through acquisition recently securing a $5 million investment to fund its acquisition campaign which has already netted the Comapany a CBD confections business, a CBD pet products business and CBD sun care business. On August 25 PURA reported it has exceeded $3 million in revenue over the trailing 12 months. Last week, the company published its Q2 2020 financials reporting $1.6 million in sales year-to-date (YTD) representing 48% revenue growth compared to the same period last year.We will be updating on PURA when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with PURA.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in PURA either long or short and we have not been compensated for this article.